Carter Robert Ross 4

What Happened
Carter Robert Ross, Chief Financial Officer of Oncology Institute, disposed of 1,604 common shares on May 21, 2026 at $4.47 per share, for proceeds of approximately $7,170. The Form 4 shows the transaction as an "other acquisition or disposition (J)" disposition; a footnote clarifies the issuer executed the sale to cover tax liabilities from the vesting of an RSU award.

Key Details

• Transaction date and price: 2026-05-21 at $4.47 per share (total ≈ $7,170).
• Transaction type: Disposition executed by issuer to satisfy tax withholding on vested RSUs (footnote).
• Shares owned after the transaction: Not disclosed in the provided filing details.
• Filing date: 2026-05-22 (filed timely; Form 4 is due within two business days).
• Footnote: Sale was to cover tax liabilities arising from the vesting of an RSU award made May 21, 2024.

Context
Sales executed by the issuer to cover taxes on vested restricted stock units (RSUs) are routine administrative transactions (tax withholding) and do not necessarily reflect the insider’s view on the company’s prospects. This was not an open-market discretionary sale by the insider.